|
2024
|
Invention
|
Use of pd-l1 low expression status to select subjects for cancer immunotherapy. The disclosure re... |
|
|
Invention
|
Use of pd-l1 low expression status to select subjects for cancer immunotherapy.
The disclosure r... |
|
|
Invention
|
Use of semaphorin-4d antibodies in combination with an immune modulating therapy to inhibit tumor... |
|
|
Invention
|
Human anti-semaphorin 4d antibody.
Compositions and method are provided for treating diseases as... |
|
2023
|
Invention
|
Anti-ccr8 antibodies and uses thereof.
The present disclosure is directed to antibodies or antig... |
|
|
Invention
|
Methods to select antibodies specific to complex membrane antigens.
This disclosure provides com... |
|
|
Invention
|
Methods to select antibodies specific to complex membrane antigens |
|
|
Invention
|
Methods to select antibodies specific to complex membrane antigens. This disclosure provides comp... |
|
|
Invention
|
Combination therapy with semaphorin-4d blockade (sema4d) and dc1 therapy. Disclosed are compositi... |
|
|
Invention
|
Combination therapy with semaphorin-4d blockade and htt-lowering agent for treatment of huntingto... |
|
2022
|
Invention
|
Human anti-semaphorin 4d antibody. Compositions and method are provided for treating diseases ass... |
|
|
Invention
|
Anti-cd100 antibodies and methods for using the same. Compositions and methods are provided for t... |
|
2021
|
Invention
|
Predictive outcome profiling for use of an anti-semaphorin-4d binding molecule to treat neurodege... |
|
|
Invention
|
Use of semaphorin-4d binding molecules for the treatment of rett syndrome. Provided herein are me... |
|
|
Invention
|
Use of cxcl13 binding molecules to promote peripheral nerve regeneration. Provided herein are met... |
|
|
Invention
|
Integral membrane protein display on poxvirus extracellular enveloped virions. This disclosure pr... |
|
|
Invention
|
Anti-ccr8 antibodies and uses thereof. The present disclosure is directed to antibodies or antige... |
|
2020
|
Invention
|
Anti-cxcl13 antibodies and methods of using the same. Compositions and methods are provided for t... |
|
|
Invention
|
Combined inhibition of semaphorin-4d and tgf.beta. and compositions therefor. Provided herein are... |
|
|
Invention
|
Combined inhibition of semaphorin-4d and tgf-beta and compositions therefor.
Provided herein are... |
|
|
Invention
|
Combined inhibition of semaphorin-4d and tgfb and compositions therefor. Provided herein are meth... |
|
|
Invention
|
Methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells.
This disclosu... |
|
|
Invention
|
Semaphorin-4d antagonists for use in cancer therapy. The disclosure relates to methods for treati... |
|
|
P/S
|
Medical and scientific antibody discovery research, namely, identifying antibodies for use in dev... |
|
2019
|
Invention
|
Use of semaphorin-4d binding molecules for treating neurodegenerative disorders. Provided herein ... |
|
|
Invention
|
Use of semaphorin-4d binding molecules for modulation of blood brain barrier permeability. Provid... |
|
|
Invention
|
Use of semaphorin-4d inhibitory molecules with an immune modulating therapy to inhibit tumor grow... |
|
|
Invention
|
Methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells. This disclosur... |
|
2018
|
Invention
|
Treatment of cancer with a semaphorin-4d antibody in combination with an epigenetic modulating ag... |
|
|
Invention
|
Early detection of glial cell activation in neurodegenerative or neuroinflammatory diseases.
The... |
|
2017
|
Invention
|
Improved methods for producing polynucleotide libraries in vaccinia virus/eukaryotic cells.
This... |
|
2005
|
P/S
|
Research and development services for others in the fields of pharmaceuticals and biotechnology. |
|
|
P/S
|
Research and development services for others in the fields of pharmaceuticals and biotechnology |
